Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components - Breakdown of the Company Revenue (Details)

v3.23.1
Balance Sheet Components - Breakdown of the Company Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Concentration Risk [Line Items]    
Revenues $ 72,162 $ 80,385
U.S. revenue    
Concentration Risk [Line Items]    
Revenues 53,190 52,444
Non-U.S. revenue    
Concentration Risk [Line Items]    
Revenues $ 18,972 $ 27,941